Litigation Details for AbbVie Inc. v. Amgen Inc. (D. Del. 2016)

AbbVie Inc. v. Amgen Inc. (D. Del. 2016)

Docket		Date Filed	2016-08-04
Court	District Court, D. Delaware	Date Terminated	2017-09-28
Cause	35:271 Patent Infringement	Assigned To	Mitchell S. Goldberg
Jury Demand	None	Referred To
Parties	ABBVIE BIOTECHNOLOGY LTD.; AMGEN INC.
Patents	8,231,876; 8,663,945; 8,715,664; 8,808,700; 8,883,156; 8,889,136; 8,895,009; 8,906,372; 8,906,373; 8,906,646; 8,911,964; 8,916,153; 8,926,975; 8,961,973; 8,961,974; 8,986,693; 8,999,337; 9,018,361; 9,061,005; 9,067,992; 9,073,988; 9,085,618; 9,085,620; 9,090,689; 9,090,867; 9,096,666; 9,102,723; 9,150,645; 9,187,559; 9,200,069; 9,200,070; 9,206,390; 9,234,032; 9,234,033; 9,255,143; 9,266,949; 9,273,132; 9,284,370; 9,284,371; 9,290,568; 9,315,574; 9,328,165; 9,334,319; 9,346,879; 9,359,434; 9,365,645
Attorneys	Evan R. Chesler; Keith R. Hummel
Firms	Greenberg Traurig, the Nemours Building; Ross Aronstam & Moritz LLP
Link to Docket	External link to docket

Biologic Drugs cited in AbbVie Inc. v. Amgen Inc.

Details for AbbVie Inc. v. Amgen Inc. (D. Del. 2016)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2016-08-04	1		Composition 9,328,165 Purified Antibody Composition 8,231,876 Purified Antibody Composition 8,663,945 … U.S Patent No. 8,916,157; U.S Patent No. 8,961,973; U.S Patent No. 8,986,693; U.S Patent No. 9,096,666… U.S Patent No. 9,220,781; U.S Patent No. 9,272,041; U.S. Patent No. 9,359,434; and U.S. Patent No. 9,365,645…United States Patent and Trademark Office (“Patent Office”) has granted AbbVie numerous patents which are…of 6 patents each, and the patents-in-suit constitute the compilation of the two lists (2 patents were	External link to document
2016-08-04	3		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,663,945; 8,911,964; 8,916,157… 28 September 2017 1:16-cv-00666 830 Patent None District Court, D. Delaware	External link to document
2017-04-27	62		owner by assignment of U.S. Patent No. 8,663,945 (“the ’945 Patent”). AbbVie has alleged that … Non-Infringement and Invalidity of U.S. Patent No. 8,663,945 38. Amgen and AML… The ’945 Patent, the ’964 Patent, the ’157 Patent, the ’973 Patent, the ’693 Patent, the …the ’666 Patent, the ’781 Patent, the ’041 Patent, the ’434 Patent, and the ’645 Patent, and each of … the ’945 Patent, the ’964 Patent, the ’157 Patent, the ’973 Patent, the ’693 Patent, the ’666	External link to document